{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:23:22Z","timestamp":1782602602146,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:00:00Z","timestamp":1537574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s13730-018-0363-9","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T06:21:30Z","timestamp":1537597290000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An autopsy case of TAFRO syndrome with membranoproliferative glomerulonephritis-like lesions"],"prefix":"10.1007","volume":"8","author":[{"given":"Keiko","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Honma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoko","family":"Ida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokichi","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Togo","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Akiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,22]]},"reference":[{"key":"363_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3960\/jslrt.53.57","volume":"53","author":"H Kawabata","year":"2013","unstructured":"Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y. Castleman-Kojima disease (TAFRO Syndrome), a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013;53:57\u201361.","journal-title":"J Clin Exp Hematop"},{"key":"363_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3960\/jslrt.53.63","volume":"53","author":"K Takai","year":"2013","unstructured":"Takai K, Nikkuni K, Motomi A, Nagai K, Igarashi N, Saeki T. Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: a clinical report of five cases. J Clin Exp Hematop. 2013;53:63\u20138.","journal-title":"J Clin Exp Hematop"},{"key":"363_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3960\/jslrt.53.69","volume":"53","author":"H Kawabata","year":"2013","unstructured":"Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Minori T, Mtsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A. Clinical features and treatment of multicentric Castleman\u2019s disease: a retrospective study of 21 Japanese patients at a single institute. J Clin Exp Hematop. 2013;53:69\u201377.","journal-title":"J Clin Exp Hematop"},{"key":"363_CR4","first-page":"320","volume":"51","author":"K Takai","year":"2010","unstructured":"Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki. 2010;51:320\u20135.","journal-title":"Rinsho Ketsueki"},{"key":"363_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12185-016-1979-1","volume":"103","author":"Y Masaki","year":"2016","unstructured":"Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, Kurose N, Ide M, Murakami J, Nara K, Yamamoto H, Ozawa Y, Takahashi H, Miura K, Miyauchi T, Yoshida S, Momoi A, Awano N, Ikushima S, Ohta Y, Furuta N, Fujimoto S, Kawanami H, Sakai T, Kawanami T, Fujita Y, Fukushima T, Nakamura S, Kinoshita T, Aoki S. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016;103:686\u201392.","journal-title":"Int J Hematol"},{"key":"363_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.hoc.2017.09.005","volume":"32","author":"R Szalat","year":"2018","unstructured":"Szalat R, Munshi NC. Diagnosis of castleman disease. Hematol Oncol Clin N Am. 2018;32:53\u201364.","journal-title":"Hematol Oncol Clin N Am"},{"key":"363_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.hoc.2017.09.010","volume":"32","author":"A Dispenzieri","year":"2018","unstructured":"Dispenzieri A, Kourelis T, Buandi F. POEMS syndrome diagnosis and investigative work-up. Hematol Oncol Clin N Am. 2018;32:119\u201339.","journal-title":"Hematol Oncol Clin N Am"},{"key":"363_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.hoc.2017.09.009","volume":"32","author":"T Igawa","year":"2018","unstructured":"Igawa T, Sato Y. TAFRO syndrome. Hematol Oncol Clin N Am. 2018;32:107\u201318.","journal-title":"Hematol Oncol Clin N Am"},{"key":"363_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3960\/jslrt.53.87","volume":"53","author":"N Iwaki","year":"2013","unstructured":"Iwaki N, Sato Y, Takata K, Kondo E, Ohno K, Takeuchi M, Orita Y, Nakao S, Yoshino T. Atypical hyaline vascular-type Castleman\u2019s disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy. J Clin Exp Hematop. 2013;53:87\u201393.","journal-title":"J Clin Exp Hematop"},{"key":"363_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3960\/jslrt.53.95","volume":"53","author":"M Inoue","year":"2013","unstructured":"Inoue M, Ankou M, Hua J, Iwaki Y, Hagihara M. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporine A: a case report. J Clin Exp Hematop. 2013;53:95\u20139.","journal-title":"J Clin Exp Hematop"},{"key":"363_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.24242","volume":"91","author":"N Iwaki","year":"2016","unstructured":"Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M, Masunari T, Yoshida I, Moro H, Nikkuni K, Takai K, Matsue K, Kurosawa M, Hagihara M, Saito A, Okamoto M, Yokota K, Hiraiwa S, Nakamura N, Nakao S, Yoshino T, Sato Y. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016;91:220\u20136.","journal-title":"Am J Hematol"},{"key":"363_CR12","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/ndt\/13.6.1556","volume":"13","author":"K Furuichi","year":"1998","unstructured":"Furuichi K, Wada T, Shimizzu M, Segawa C, Ohta S, Takasawa K, Kobayashi K, Yokoyama H. Antimyeloperoxidase-antibody-positive rapidly progressive glomerulonephritis associated with Castleman\u2019s disease. Nephrol Dial Transplant. 1998;13:1556\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"363_CR13","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2169\/internalmedicine.52.9482","volume":"52","author":"H Kawabata","year":"2013","unstructured":"Kawabata H, Kotani S, Matsumura Y, Kondo T, Katsurada T, Haga H, Kadowaki N, Takaori-Kondo A. Successful treatment of a patient with multicentric Castleman\u2019s disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. Intern Med. 2013;52:1503\u20137.","journal-title":"Intern Med"},{"key":"363_CR14","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12185-016-1978-2","volume":"103","author":"S Fujiwara","year":"2016","unstructured":"Fujiwara S, Mochinaga H, Nakata H, Ohshima K, Matsumoto M, Uchida M, Mikami Y, Hata H, Okuno Y, Mitsuya H, Nosaka K. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids. Int J Hematol. 2016;103:718\u201323.","journal-title":"Int J Hematol"},{"key":"363_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1620\/tjem.236.289","volume":"236","author":"Y Konishi","year":"2015","unstructured":"Konishi Y, Takahashi S, Nishi K, Sakamaki T, Mitani S, Kaneko H, Mizutani C, Ukyo N, Hirata H, Tsudo M. Successful treatment of TAFRO syndrome, a variant of multicentric Castleman\u2019s disease, with cyclosporine A: possible pathogenetic contribution of interleukin-2. Tohoku J Exp Med. 2015;236:289\u201395.","journal-title":"Tohoku J Exp Med"},{"key":"363_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2169\/internalmedicine.55.4710","volume":"55","author":"Y Yamaga","year":"2016","unstructured":"Yamaga Y, Tokuyama K, Kato T, Yamada R, Murayama M, Ikeda T, Yamakita M, Kunieda T. Successful treatment with cyclosporin A in tocilizumab-resistant TAFRO syndrome. Intern Med. 2016;55:185\u201390.","journal-title":"Intern Med"},{"key":"363_CR17","first-page":"350","volume":"55","author":"T Ozawa","year":"2013","unstructured":"Ozawa T, Kosugi S, Kito M, Onishi M, Kida T, Nakata S, Take H, Katagiri S. Efficacy of rituximab for a variant type of multicentric Castleman\u2019s disease termed the TAFRO syndrome. Rinsho Ketsueki. 2013;55:350\u20135.","journal-title":"Rinsho Ketsueki"},{"key":"363_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3960\/jslrt.53.79","volume":"53","author":"Y Masaki","year":"2013","unstructured":"Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H. Japanese variant of multicentric Castleman\u2019s disease associated with serositis and thrombocytopenia\u2014a report of two cases: Is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop. 2013;53:79\u201385.","journal-title":"J Clin Exp Hematop"},{"key":"363_CR19","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.amjmed.2016.05.010","volume":"129","author":"A Tadokoro","year":"2016","unstructured":"Tadokoro A, Kanaji N, Hara T, Matsumoto K, Ishii T, Takagi T, Watanabe N, Kita N, Kawauchi M, Ueno M, Kadowaki N, Bandoh S. An uncharted constellation: TAFRO syndrome. Am J Med. 2016;129:938\u201341.","journal-title":"Am J Med"},{"issue":"13","key":"363_CR20","doi-asserted-by":"publisher","first-page":"e6271","DOI":"10.1097\/MD.0000000000006271","volume":"96","author":"FF Jos\u00e9","year":"2017","unstructured":"Jos\u00e9 FF, Kerbauy LN, Perini GF, Blumenschein DI, Pasqualin DC, Malheiros DMAC, Neto GCC, Santos FPS, Piovesan R, Hamerschlak N. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids. Medicine. 2017;96(13):e6271.","journal-title":"Medicine"},{"key":"363_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.03.021","author":"H Mizuno","year":"2018","unstructured":"Mizuno H, Sekine A, Oguro M, Oshima Y, Kawada M, Sumida K, Yamanouchi M, Hayami N, Suwabe T, Hiramatsu R, Hasegawa E, Hoshino J, Sawa N, Fujii T, Takaichi K, Ohashi K, Ubara Y. Renal histology in a patient with TAFRO syndrome: a case report. Hum Pathol. 2018. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2018.03.021\n                    \n                  .","journal-title":"Hum Pathol"},{"issue":"40","key":"363_CR22","doi-asserted-by":"publisher","first-page":"e8216","DOI":"10.1097\/MD.0000000000008216","volume":"96","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Tsujimoto H, Yamamoto K, Shimoda S, Oka K, Takeoka H. Clinicopathological features of progressive renal involvement in TAFRO syndrome. Medicine. 2017;96(40):e8216.","journal-title":"Medicine"},{"key":"363_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-018-0338-x","author":"T Ozeki","year":"2018","unstructured":"Ozeki T, Tsuji M, Yamamoto J, Shigematu C, Maruyama S. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome. Cen Case Rep. 2018. \n                    https:\/\/doi.org\/10.1007\/s13730-018-0338-x\n                    \n                  .","journal-title":"Cen Case Rep"},{"issue":"24","key":"363_CR24","doi-asserted-by":"publisher","first-page":"e11057","DOI":"10.1097\/MD.0000000000011057","volume":"97","author":"Y Furuto","year":"2018","unstructured":"Furuto Y, Hashimoto H, Horiuti H, Shibuya Y. Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: a case report. Medicine. 2018;97(24):e11057.","journal-title":"Medicine"},{"issue":"supple3","key":"363_CR25","doi-asserted-by":"publisher","first-page":"iii119","DOI":"10.1093\/ndt\/gfr245","volume":"27","author":"D Xu","year":"2012","unstructured":"Xu D, Lv J, Dong Y, Wang S, Su T, Zhou F, Zou W, Zhao M, Zhang H. Renal involvement in a large cohort of Chinese patients with Castleman disease. Nephrol Dial Transplant. 2012;27(supple3):iii119\u201325.","journal-title":"Nephrol Dial Transplant"},{"key":"363_CR26","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1093\/ndt\/14.10.2370","volume":"14","author":"Y Nakamoto","year":"1999","unstructured":"Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura AB. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant. 1999;14:2370\u20138.","journal-title":"Nephrol Dial Transplant"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-018-0363-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-018-0363-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-018-0363-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T19:17:34Z","timestamp":1569093454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-018-0363-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,22]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["363"],"URL":"https:\/\/doi.org\/10.1007\/s13730-018-0363-9","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,22]]},"assertion":[{"value":"15 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}